Concepedia

Bharat K. R. Chaganty

BK

Statistics

Publications

12

Citations

685

H-Index

11

Active since

2009

Affiliations

Texas Center for Infectious Disease(Current)

The University of Texas at San Antonio

The University of Texas at San Antonio Health Science Center

The University of Texas MD Anderson Cancer Center

Midwestern University

Bharat K. R. Chaganty is an author at Texas Center for Infectious Disease specializing in immunology, immunology of infectious diseases, and infectious diseases.

ORCID

Publications per year

2009–2020

12

Publications

12

Trastuzumab upregulates PD-L1 as a potential mechanism of trastuzumab resistance through engagement of immune effector cells and stimulation of IFNγ secretion

Bharat K. R. Chaganty, Songbo Qiu, Anneliese M. M. Gest et al. · Cancer Letters · 2018 · 204 citations

, , +17

Tumor Necrosis Factor Alpha Production from CD8<sup>+</sup>T Cells Mediates Oviduct Pathological Sequelae following Primary Genital Chlamydia muridarum Infection

Ashlesh K. Murthy, Weidang Li, Bharat K. R. Chaganty et al. · Infection and Immunity · 2011 · 140 citations

, , +14

Acetyl-CoA carboxylase rewires cancer metabolism to allow cancer cells to survive inhibition of the Warburg effect by cetuximab

Jingtao Luo, Yun Hong, Yang Lü et al. · Cancer Letters · 2016 · 100 citations

, , +17

VIS832, a novel CD138-targeting monoclonal antibody, potently induces killing of human multiple myeloma and further synergizes with IMiDs or bortezomib in vitro and in vivo

Tengteng Yu, Bharat K. R. Chaganty, Liang Lin et al. · Blood Cancer Journal · 2020 · 43 citations · Full text

, , +17

Trastuzumab upregulates expression of HLA-ABC and T cell costimulatory molecules through engagement of natural killer cells and stimulation of IFNγ secretion

Bharat K. R. Chaganty, Yang Lü, Songbo Qiu et al. · OncoImmunology · 2015 · 41 citations · Full text

, , +17

1–5 of 12